REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/22/2026
Back to search
Official data from USPTO
LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/23/2026
Trademark type
Combined
Nice classes
5, 35, 39
Filing date
04/21/2020
Registration date
06/22/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/22/2021
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
RU
Examiner
MCCARTHY, BRIDGET ANN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LIPOLYTIC" where the "L" is blue and "IPOLYTIC" is in gray font. To the left of the wording are four vertical lines of various widths, from thin to thickest, that are different shades of blue. Under the wording "LIPOLYTIC" is the numbers "37.5" in white on a blue rectangle. Under the "37.5", is the wording "60 CAPSULES" in blue. Under this wording is a blue horizontal line. Under the line, is the stylized wording "TRI PHARMA COMPANY" in black font, to the right of a stylized gray triangle. The entire image is on a white background.
Holders and representatives
Holders
TRI-PHARMA Limited Liability Company
Representatives
Thomas Tatonetti Tatonetti IP
Technical classification
Nice Classes
Class 5Class 35Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
dietetic substances adapted for medical use in the nature of dietetic foods adapted for medical use; buckthorn barks for pharmaceutical purposes; biological preparations for medical purposes for the treatment of obesity; albuminous foodstuffs for medical purposes in the nature of medicated supplements with vegetable raw materials containing Caralluma fimbriata
Class 35
public opinion polling; conducting marketing studies; marketing services; commercial intermediation servicesbusiness management consulting and advisory services; web indexing for commercial or advertising purposescompiling indexes of information; presentation of goods on communication mediafor retail purposes in the nature of providing television home shopping services in the field of general consumer merchandise; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; direct mail advertising services; advertising services
Class 39
Delivery of goods; delivery of goods by mail order; packaging of goods; wrapping of goods in the nature of gift wrapping; storage of goods
Publications
History of USPTO decisions and trademark events.
33 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/13/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/13/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
10/13/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/22/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/22/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/01/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/25/2021
GNFR
FINAL REFUSAL E-MAILED
02/25/2021
CNFR
FINAL REFUSAL WRITTEN
02/25/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2021
ALIE
ASSIGNED TO LIE
02/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2020
RFNT
REFUSAL PROCESSED BY IB
08/30/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/11/2020
RFRR
REFUSAL PROCESSED BY MPU
08/11/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/18/2020
CNRT
NON-FINAL ACTION WRITTEN
07/17/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/14/2020
DOCK
ASSIGNED TO EXAMINER
07/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/09/2020
Continuous trademark protection
Get notified about every new filing that threatens LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.